These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1160427)

  • 21. [Comparative study of treatment with the classical method and with Ulcosilvanil in gastroduodenal ulcer].
    Dumitrasçu D; Acalovschi M; Andreica V; Badea G; Drăghici A; Georoceanu A; Grănescu S; Lencu M; Marin M; Pascu O
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(6):529-40. PubMed ID: 2871611
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of oxyferriscorbon in peptic ulcer].
    Spivak AM; Galetskaia TM; Liashko NA; Okhonko VI
    Vrach Delo; 1973 Apr; 4():19-22. PubMed ID: 4712061
    [No Abstract]   [Full Text] [Related]  

  • 23. [epsilon-Zinc acetamide caproate versus cimetidine in the treatment of peptic ulcer. Randomized study].
    Navarro S; Piqué JM; García Pugés AM; Vilar Bonet J
    Med Clin (Barc); 1985 Dec; 85(20):831-4. PubMed ID: 3910976
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sodium carbenoxalone in the treatment of peptic ulcer of the stomach].
    Manuel de Marcos Perez
    Rev Esp Enferm Apar Dig; 1967; 26(6):733-42. PubMed ID: 5606676
    [No Abstract]   [Full Text] [Related]  

  • 25. Bismuth compounds in the treatment of peptic ulcer: a review.
    Nanivadekar SA
    J Assoc Physicians India; 1990 Sep; 38 Suppl 1():736-42. PubMed ID: 2092031
    [No Abstract]   [Full Text] [Related]  

  • 26. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endoscopic follow-up of recurrences of gastroduodenal ulcer after treatment with Ulcosilvanil (4-year study)].
    Puşcaş I; Buzáş G; Voicu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(4):357-9. PubMed ID: 6140734
    [No Abstract]   [Full Text] [Related]  

  • 28. [Aminocaproic acid electrophoresis in the complex treatment of peptic ulcer].
    Balashov VI
    Vrach Delo; 1972 Dec; 12():22-6. PubMed ID: 4659206
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative evaluation of the therapeutic effect of oxyferriscorbone in peptic ulcer].
    Spivak AM; Reĭngardt VK; Galetskaia TM; Liashko NA; Litinskaia EV
    Vrach Delo; 1985 Aug; (8):56-9. PubMed ID: 4072113
    [No Abstract]   [Full Text] [Related]  

  • 30. [Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
    Il'chenko AA; Zurabishvili NG; Zhukhovitskiĭ BG; Gorodinskaia VS
    Ter Arkh; 1991; 63(2):21-6. PubMed ID: 2048016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of patients with peptic ulcer].
    Sakharchuk II; Onishuk VF
    Vrach Delo; 1968 Sep; 9():19-22. PubMed ID: 5740297
    [No Abstract]   [Full Text] [Related]  

  • 33. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.
    Berstad A; Hatlebakk JG; Wilhelmsen I; Berstad K; Bang CJ; Nysaeter G; Hausken T; Weberg R; Nesje LB; Hjartholm AS
    Hepatogastroenterology; 1995; 42(5):655-9. PubMed ID: 8751230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of peptic ulcer. Bismuth salts].
    Börsch G
    Verh Dtsch Ges Inn Med; 1988; 94():284-92. PubMed ID: 3061197
    [No Abstract]   [Full Text] [Related]  

  • 35. [Progress in the pharmacotherapy of peptic ulcer].
    Stasiewicz J; Moniuszko-Jakoniuk J
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1721-5. PubMed ID: 6151657
    [No Abstract]   [Full Text] [Related]  

  • 36. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experiences with Bisuc in stomach diseases].
    Bartenschlager HM
    Z Allgemeinmed; 1973 Jun; 49(17):853-5. PubMed ID: 4580315
    [No Abstract]   [Full Text] [Related]  

  • 38. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot trial of a colloidal bismuth preparation in the treatment of peptic ulcer.
    Weiss G; Kallmeyer JC
    S Afr Med J; 1968 Mar; 42(13):317-20. PubMed ID: 4869603
    [No Abstract]   [Full Text] [Related]  

  • 40. [Reparative agents in the treatment of patients with peptic ulcer].
    Kreĭdich AM; Perepel'chenko AI; Tsymbaliuk VT; Ostapenko GI; Pan'ko LM
    Vrach Delo; 1988 Aug; (8):7-9. PubMed ID: 3206889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.